Literature DB >> 19495830

Translating Dutch: challenges and opportunities in reforming health financing in Ireland.

P Ryan1, S Thomas, C Normand.   

Abstract

In 2006, Dutch authorities introduced a new health financing system of compulsory private for-profit insurance with strong government regulation. This system has recently attracted attention in Ireland. This paper assesses the theoretical arguments and evidence for applying the Dutch ideas to Ireland. In particular, the authors address how it would help the stated health system policy objectives of improving value for money, fairness and capacity. While the current Dutch reform is still a work in progress, it offers the headline attraction of a single tier system with few waiting lists. Nevertheless, the Dutch system of managed competition may entail risks for Ireland relating to ensuring sufficient system capacity, protecting those on low-incomes and ensuring cost control.

Entities:  

Mesh:

Year:  2009        PMID: 19495830     DOI: 10.1007/s11845-009-0365-x

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  9 in total

1.  Equity in the finance of health care: some further international comparisons.

Authors:  A Wagstaff; E van Doorslaer; H van der Burg; S Calonge; T Christiansen; G Citoni; U G Gerdtham; M Gerfin; L Gross; U Häkinnen; P Johnson; J John; J Klavus; C Lachaud; J Lauritsen; R Leu; B Nolan; E Perán; J Pereira; C Propper; F Puffer; L Rochaix; M Rodríguez; M Schellhorn; O Winkelhake
Journal:  J Health Econ       Date:  1999-06       Impact factor: 3.883

2.  Tracking health care costs: inflation returns.

Authors:  C Hogan; P B Ginsburg; J R Gabel
Journal:  Health Aff (Millwood)       Date:  2000 Nov-Dec       Impact factor: 6.301

3.  Health spending projections for 2002-2012.

Authors:  Stephen Heffler; Sheila Smith; Sean Keehan; M Kent Clemens; Greg Won; Mark Zezza
Journal:  Health Aff (Millwood)       Date:  2003 Jan-Jun       Impact factor: 6.301

4.  Going Dutch--managed-competition health insurance in the Netherlands.

Authors:  Alain C Enthoven; Wynand P M M van de Ven
Journal:  N Engl J Med       Date:  2007-12-13       Impact factor: 91.245

5.  An experiment with regulated competition and individual mandates for universal health care: the new Dutch health insurance system.

Authors:  Pauline Vaillancourt Rosenau; Christiaan J Lako
Journal:  J Health Polit Policy Law       Date:  2008-12       Impact factor: 2.265

6.  Learning and mislearning across borders: what can we (not) learn from the 2006 health care reform in the Netherlands? Commentary on Rosenau and Lako.

Authors:  Kieke G H Okma
Journal:  J Health Polit Policy Law       Date:  2008-12       Impact factor: 2.265

7.  Managed competition in the Netherlands: still work-in-progress.

Authors:  Wynand P M M Van de Ven; Frederik T Schut
Journal:  Health Econ       Date:  2009-03       Impact factor: 3.046

8.  A historical analysis of medical spending growth, 1960-1993.

Authors:  E A Peden; M S Freeland
Journal:  Health Aff (Millwood)       Date:  1995       Impact factor: 6.301

Review 9.  The Irish health system: developments in strategy, structure, funding and delivery since 1980.

Authors:  Miriam M Wiley
Journal:  Health Econ       Date:  2005-09       Impact factor: 3.046

  9 in total
  2 in total

1.  A framework for assessing health system resilience in an economic crisis: Ireland as a test case.

Authors:  Steve Thomas; Conor Keegan; Sarah Barry; Richard Layte; Matt Jowett; Charles Normand
Journal:  BMC Health Serv Res       Date:  2013-10-30       Impact factor: 2.655

2.  "Managed competition" for Ireland? The single versus multiple payer debate.

Authors:  Misja Mikkers; Padhraig Ryan
Journal:  BMC Health Serv Res       Date:  2014-09-26       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.